The depressive states concerned in this communication are limited to those encountered in the out-patient department of the. neuropsychiatric service of a general hospital and in the consulting room. In order to simplify an already somewhat complex presentation and for the sake of brevity we have omitted depressions in hospitalized patients and in children. We shall limit ourselves therefore to a brief survey of therapy with Tofranil t in adult depressive patients not confined to hospital. Our choice of patients has been dictated primarily by the concept of the depressive state, independently of etiology or nosology. We shall not deal with the chemistry, toxicity or pharmacology of Tofranil since a complete study of this is already to be found in the literature on the subject.
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In common with many other investigators, we have noticed the euphoric action of Tofranil, its variable but on the whole beneficial effects on the neurovegetative symptomatology, the relapses which occur on premature interruption of treatment, and the sometimes spectacular recurrence of the remission on giving the drug again. We have seen the importance of continuing therapy after the remission. Secondary effects -not very common -such as dryness of the mouth and excessive sweating, the variable effect of the drug on psychotic symptoms, on anxiety and on behaviour have also been noted. But most of all we have been struck by thẽ significant modifications we have observed in the sense of time and of the past in our patients. We shall return to this later.
Our clinical material comprised adult persons of both sexes, not hospitalized, with little or no deterioration, with varying degrees of depression and without distinction as regards history of the case, etiology and nosology. The ages ranged from 26 to 79 with an average of 51. Our criteria for the gravity of the condition have not been fixed systematically but they approximate to those given by Lehmann (1) and his co-workers.
About a third of our patients were given, concomitantly or previously, electroshock therapy because of the urgency of the situation as regards the risk of suicide. The majority of these patients received only a limited number of electroshocks. Most of the patients who had already received electroshock therapy on a previous occasion were rapidly improved after 2 or 3 shocks, and improvement was then maintained by Tofranil alone. Two-thirds of our patients received Tofranil only. We gave this at first intramuscularly and then by mouth at the beginning of our investigations, but in view of the fact that results by mouth were similar to those obtained intramuscularly we employed only the oral route after April, 1958. The average dose was 150 mg a day, and we never gave more than 250 mg or less than 100 mg a day. The maintenance dose given to all our patients, whether cured, much improved or sufficiently improved to "function" in their habitual environment, was 50-75 mg a day.
In some patients we observed relapse or signs of imminent relapse when we interrupted Tofranil treatment prematurely. It seems to us too early yet to be able to judge with confidence when the drug can be discontinued without risk of relapse, in spite of our experience with such patients. The classical criteria for improvement or cure in depressive states are, as we are aware, the change in mood and the return of some degree of optimism, accelera-*Translation. **Departments of Neurology and Psychiatry, University of Montreal, and the Hotel-Dieu Hospital Montreal tTrade Mark, tion in psychomotor responses, raising of the anxiety threshold, disappearance of hallucinations, progressive improvement in interpersonal relationship, improvement in sleep and appetite and increase in weight. All these criteria are sufficiently objective not to escape the attention of even the least experienced observer.
Before considering other means of evaluating cures it is worth noting that endogenous depressions, the manic-depressive type, and involutional melancholia, respond favourably to Tofranil in more than a third of the cases, but neurotic depressions respond poorly. Mixed psychoneuroses with hysterical, obsessional and hypochondriacal elements were completely unaffected in our series of cases, and the same applied to depressions associated with schizophrenia, depressions of old age, and those associated with paranoid states and organic cerebral lesions.
Our results are shown in the accompanying table. These figures agree well with those obtained by other authors except that the improvements in endogenous depression and failures in depressions associated with mixed psychoneuroses seem even more sharply contrasted in our statistics. Between these two extremes lies an intermediate group of neurotic depressions or depressions associated with other morbid conditions. We were considerably struck by this grouping. We have to admit that our statistical data based on empirical clinical findings lack the strict accuracy of quantitative measurements and the dogmatic appeal of a double blind test. Nevertheless they were obtained by two observers with differing personalities, working separately on two different groups of patients, the sole criterion for the administration of Tofranil being the existence of a depressive syndrome. The results observed in each group -45 and 31 cases respectivelyare identical. In our view it is more logical to explain this identity as a statement of fact than as a similarity of errors and interpretation.
What is the explanation of these statistical results? At first we had expected a uniform improvement in depressive states treated with Tofranil. We hoped that the common denominator among all our patients, the depression, would diminish in similar ratio among all groups. To our surprise this ratio was not revealed in relation to the depression as such but was revealed in relation to different diagnostic data. Thus the depressive syndrome of despondency, tears, asthenia, adynamia, loss of interest, etc., common to all our cases remained unchanged in the organic diseases, in the paranoid reactions, mixed psychoneuroses and schizophrenia, improved noticeably in the neurotic depressions and almost always improved in the depressive states of manic-depressive psychosis.
CANADIAN PSYCHIATRIC ASSOCIATION JOURNAL Vol. 4, 1959 These facts have caused us to question the psychiatric concept of depression and the presumed mode of action of Tofranil. Consequently the definition of depression requires some revision. We already know that the concept must not be confused with that given by physiologists. There are far too many definitions of depression. Some are too simple, some too elaborate. We have taken the simplest from Regis (2): "Depression is a reaction of sadness, active or passive, with diminution of spontaneous action, sometimes to the extent of complete suspension of all activity and sometimes accompanied by agitation."
Ey (3) has formulated a more complete definition in connection with melancholia: "A depressive state, generally paroxysmal, characterized by a despondent toning of the contents of consciousness, lack of will, intellectual inhibition, pessimistic ideation and anxiety."
Sullivan (4) is more laconic: "Depression is a preoccupation of consciousness, nourished by ideas of gloom and involving considerable reduction of activity."
Diethelm (5) sums up the essence of depression thus: "A pathological disturbance of mood, related to Kraepelin's manic-depressive psychosis, involving genetic and psychodynamic elements." For Binswanger (6) the essential elements of the psychopathology of depressive states of endogenous origin are their ultimate determination by the past and "the supremacy of what has been."
In current language the term depression qualifies a state common to different morbid conditions, in which the intensity varies from that of a simple depression to a state of stupor.
In view of the results obtained, and from the hypothesis that Tofranil acts directly on the element of depression, we have to realize the disparity between different forms of depression, since we cannot otherwise account for the selective antidepressive effect of Tofranil, It is possible, on the other hand, that the unity of depressive syndromes put forward here is only an apparent one, for we can visualize that Tofranil is not just a depressive or antidepressive agent but perhaps modifies certain depressogenic factors.
Analysis of our cases enables us to find a common clinical denominator applicable to all those that improved. In fact, apart from the feeling of guilt-ridden grief, the episodic agitation, pessimistic mental content, etc., we were struck by the frequent allusions of our patients to their experience of time and to their feeling about the absence of passage of time. They gave the impression of living in a state of arrest, of mentally marking time in a situation where the only existential modality seemed to be a continual reliving of the past. They appeared to be unable to inject themselves into the reality of the present and incapable of integrating themselves into the perspective of the future. The first step toward progress, noticed by those around them before they remarked it themselves, was the entrance of these patients into the reality of the present. Next, their progress toward normality was emphasized by their ability to reshape the past, which already appeared less formidable against a background of future possibilities.
This constant presence of the element of time seems to us to transcend the depressive phenomenon, and throws doubt on the opinion commonly held that mood is the primary factor in depression. In our experience the depressive phenomena seem to be secondary to a more fundamental alteration of the personality where the basic disorder is one of consciousness of subjective time. By modifying the disturbed state of consciousness, Tofranil may cause a disappearance of depressive symptoms which are merely secondary to the disorder of temporality.
This psychopathological hypothesis would be in line with the existential concept of mental disease.
Finally, on a physical basis, the diffuse perception or feeling of subjective temporality might be localized hypothetically and through semeiological analogy in the neighborhood of the arousal center, i.e. in the pedunculo-hypothalamic region. In this case, if we pursue the same hypothesis, the present would become more re-enacted, as it were, whereas the past would become dormant and blurred.
This broad hypothesis, in spite of its gaps, seems promising enough to tempt us to pursue our observations in a definitely biopsychological direction.
Resume
Les auteurs rapportent les resultats de l'observation de 76 cas d'etats depressifs traites par le Tofranil, Dans l'ensemble, ces resultats sont sensiblement comparables aceux qui furent publies jusqu'a maintenant; cependant, les auteurs ont ete frappes par l'action selective du Tofranil sur certains etats depressifs -les depressions endogenes en particulier -et par l'echec relatif de son action dans les depressions nevrotiques, simples et associees ad'autres modalites nevrotiques, de merne que dans les depressions schizo-affectives, seniles, paranoides ou associees a d' autres maladies organiques. 11s croient voir une correlation entre les succes du Tofranil et la pathologie du temps. 11s suggerent l'hypothese que le desordre de la conscience temporelle subjective pourrait etre al'origine des depressions endogenes et que le Tofranil mcdifierait primitivement ce desordre initiateur des etats depressifs.
